Inflammation and cancer: causes and consequences (Q37690562)

22 August 2017

1 reference

title

Inflammation and cancer: causes and consequences (English)

1 reference

22 August 2017

0 references

M M Moore

1

1 reference

22 August 2017

W Chua

series ordinal

2

1 reference

22 August 2017

K A Charles

series ordinal

3

1 reference

22 August 2017

S J Clarke

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

10 February 2010

1 reference

Clinical Pharmacology & Therapeutics

22 August 2017

1 reference

22 August 2017

87

1 reference

22 August 2017

4

1 reference

22 August 2017

504-508

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2009.254

22 August 2017

0 references

cites work

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

A systematic review of the association between circulating concentrations of C reactive protein and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Systemic inflammation, nutritional status and survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Elevation of cytokine levels in cachectic patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Predicting the toxicity of weekly docetaxel in advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Serum interleukin-6 levels reflect the disease status of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.254

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.254

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference